Literature DB >> 12809395

Effect of timing of chest tube removal on development of pericardial effusion following cardiac surgery.

Hakan Gercekoglu1, Naz Bige Aydin, Bahadir Dagdeviren, Vedat Ozkul, Tufan Sener, Murat Demirtas, Tuna Tezel, Ergin Eren, Azmi Ozler.   

Abstract

BACKGROUND: There are no standard criteria for the timing of drain removal. The objective of this study was to determine whether the macroscopic appearance of chest tube drainage fluid to serosanguineous may be used as a criteria for drain removal.
METHODS: 2,359 patients were assessed retrospectively and 80 randomized patients were followed prospectively who underwent cardiac surgery. In both parts of the study, patients were divided into two groups according to the timing of drain removal. Group I consisted of patients whose chest tubes were removed as soon as the macroscopic appearance of the drainage fluid turned to serosanguineous. Group II consisted of patients whose chest tubes were removed at the second postoperative day when the drainage output declined to less than 50 mL in a five-hour period. In the retrospective part, cases of hemodynamically significant pericardial effusion observed within seven days postoperatively were reviewed. In the prospective part, just before the drain removal, the fluid sample hematocrit obtained from the drain lines and patients' blood hematocrit were measured and recorded. Patients were evaluated with echocardiography for pericardial effusion.
RESULTS: No statistically significant difference was detected in the frequency of hemodynamically significant pericardial effusion and incidence or amount of pericardial effusion between the two study groups. The drain hematocrit to blood hematocrit ratios before drain removal showed a significant correlation with pericardial effusion. The strength of correlation between the drain hematocrit to blood hematocrit ratios before drain removal and pericardial effusion was also studied using receiver operating characteristic curve, which suggests that a drain hematocrit to blood hematocrit ratio of < or = 0.3 is strongly predictive that pericardial effusion would be absent or mild between the fifth and seventh postoperative days.
CONCLUSIONS: It is safe to remove the chest tubes as soon as the macroscopic appearance of the drainage fluid turns to serosanguineous since this practically indicates cessation of active bleeding.

Entities:  

Mesh:

Year:  2003        PMID: 12809395     DOI: 10.1046/j.1540-8191.2003.02020.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  Right pericardial window opening: a method of preventing pericardial effusion.

Authors:  Onur Sen; Unal Aydin; Taner Iyigun; Adem Reyhancan; Barış Timur; Ersin Kadirogullari; Safa Gode; Erhan Kutluk; Burak Onan
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-26

2.  Safety and Efficacy of Indomethacin for Reducing Chest Tube Duration After Coronary Artery Bypass Grafting Surgery.

Authors:  Caitlin M Gibson; Brenton Hall; Hyanggi Irene Kwon; Sondra Davis; Darien Bradford; Meredith L Howard
Journal:  J Pharm Technol       Date:  2022-01-28

3.  Delayed cardiac tamponade after open heart surgery - is supplemental CT imaging reasonable?

Authors:  Bernhard Floerchinger; Daniele Camboni; Simon Schopka; Philipp Kolat; Michael Hilker; Christof Schmid
Journal:  J Cardiothorac Surg       Date:  2013-06-24       Impact factor: 1.637

4.  Early chest tube removal after coronary artery bypass graft surgery.

Authors:  Mohsen Mirmohammad-Sadeghi; Ali Etesampour; Mojgan Gharipour; Zeinab Shariat; Peyman Nilforoush; Mahmoud Saeidi; Mahsa Mackie; Fatemeh Mirmohamad Sadeghi
Journal:  N Am J Med Sci       Date:  2009-12

5.  Efficacy of Statin Therapy Related to Baseline Renal Function in Patients with Rheumatic Heart Disease Undergoing Cardiac Surgery.

Authors:  Rongjun Zou; Wanting Shi; Jun Tao; Xifeng Lin; Dingwen Zhang; Songran Yang; Ping Hua
Journal:  Biomed Res Int       Date:  2018-04-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.